Immunovant Sciences GmbH
Biotechnology · Basel, Basel-Stadt
Immunovant Sciences GmbH is a Swiss biotechnology company based in Basel, Canton of Basel-Stadt, listed in the Swiss commercial register since 2018 (UID CHE-297.527.393).
Board members & signatories
- Christian Mauriand — Geschäftsführer
- Immunovant Sciences Holdings Limited (Company No. 11460737) — Gesellschafter
- Nandini Devi
Registered purpose
Die Gesellschaft bezweckt den Erwerb, die Entwicklung sowie die Vermarktung von biopharmazeutischen Produkten. Die Gesellschaft kann alle Geschäfte eingehen und Verträge abschliessen, die geeignet sind, den Zweck der Gesellschaft zu fördern, oder die direkt oder indirekt damit im Zusammenhang stehen. Die Gesellschaft kann sich an anderen Unternehmen beteiligen oder sich mit diesen zusammenschliess…
Source: Swiss commercial register (Zefix / SOGC) and Alpintel analysis · Data as of March 2026
What Immunovant Sciences does
OFFERING
Immunovant Sciences GmbH is focused on developing therapies for autoimmune diseases, particularly through its investigational product, imeroprubart (IMVT-1402), a fully human monoclonal antibody targeting FcRn. This product aims to reduce harmful immunoglobulin G (IgG) autoantibodies and is designed for subcutaneous injection, with dosing adaptable to disease stage and severity.
Unlock the full analysis →Similar companies
- ImmunOs Therapeutics AG — Pharmaceuticals · Schlieren
- Genevant Sciences GmbH — Biotechnology · Basel
- NovImmune SA — Biotechnology · Plan-les-Ouates
- Engimmune Therapeutics AG — Biotechnology · Allschwil
- Vaximm AG — Pharmaceuticals · Basel
- Roivant Sciences GmbH — Biotechnology · Basel
Find every biotechnology company in Switzerland
Alpintel searches all 710,000 Swiss companies with AI — filter by industry, size, revenue, region and ownership in seconds.
family-owned biotechnology companies with 50+ employees…Search →Full profiles from CHF 49/month · Cancel anytime